Michael Miller
Directeur/Membre du Conseil chez PUMA BIOTECHNOLOGY, INC.
Fortune : 211 587 $ au 30/04/2024
Profil
Michael Patrick Miller is an Independent Director at Puma Biotechnology, Inc. and BioXcel Therapeutics, Inc. He is also a Director at the Zane Beadles Parade Foundation.
Previously, he held positions as a Director at The Leukemia & Lymphoma Society, Inc. and Allena Pharmaceuticals, Inc. He served as Vice President at ALZA Corp.
from 1997 to 2001 and at Genentech, Inc. from 2006 to 2010.
He was also Vice President of Commercial Operations at Cellegy Pharmaceuticals, Inc. Additionally, he served as Chief Commercial Officer & Senior Vice President at VIVUS, Inc. from 2010 to 2014 and as Senior Vice President of Sales & Marketing at Connetics Corp.
from 2003 to 2005.
From 2014 to 2020, he was the Executive Vice President of Commercial at Jazz Pharmaceuticals Plc.
Mr. Miller holds undergraduate and graduate degrees from Duke University, an MBA from San Francisco State University, and an undergraduate degree from the University of San Francisco.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
PUMA BIOTECHNOLOGY, INC.
0,09% | 22/04/2024 | 43 358 ( 0,09% ) | 211 587 $ | 30/04/2024 |
Postes actifs de Michael Miller
| Sociétés | Poste | Début |
|---|---|---|
| PUMA BIOTECHNOLOGY, INC. | Directeur/Membre du Conseil | 23/02/2018 |
| BIOXCEL THERAPEUTICS, INC. | Directeur/Membre du Conseil | 01/07/2022 |
| Zane Beadles Parade Foundation | Directeur/Membre du Conseil | - |
Anciens postes connus de Michael Miller
| Sociétés | Poste | Fin |
|---|---|---|
| JAZZ PHARMACEUTICALS PLC | Corporate Officer/Principal | 31/03/2020 |
| VIVUS, INC. | Corporate Officer/Principal | 16/01/2014 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Sales & Marketing | 01/04/2010 |
Connetics Corp.
 Connetics Corp. BiotechnologyHealth Technology Connetics Corp. develops and commercializes dermatology products. The firm offers remedies for psoriasis in adults, eczema, seborrheic dermatitis, and acne. The company was founded in 1993 and is headquartered in Palo Alto, CA. | Sales & Marketing | 01/12/2005 |
| ALZA CORPORATION | Corporate Officer/Principal | 01/01/2001 |
Formation de Michael Miller
| Duke University | Graduate Degree |
| San Francisco State University | Masters Business Admin |
| University of San Francisco | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 4 |
|---|---|
| PUMA BIOTECHNOLOGY, INC. | Health Technology |
| JAZZ PHARMACEUTICALS PLC | Health Technology |
| BIOXCEL THERAPEUTICS, INC. | Health Technology |
| ALLENA PHARMACEUTICALS, INC. | Health Technology |
| Entreprise privées | 7 |
|---|---|
ALZA Corp.
 ALZA Corp. Pharmaceuticals: MajorHealth Technology ALZA Corp. provides drug delivery solutions and develops pharmaceutical products. The company applies its delivery technologies to develop pharmaceutical products with enhanced therapeutic value for its own portfolio and for many of the world's leading pharmaceutical companies. The company was founded by Martin Gerstel and Alejandro Zaffaroni in 1968 and is headquartered in Vacaville, CA. | Health Technology |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
Cellegy Pharmaceuticals, Inc.
 Cellegy Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Cellegy Pharmaceuticals specialty biopharmaceutical company, that is primarily engaged in the development and commercialization of prescription drugs targeting women’s health care, including reduction in transmission of HIV and female sexual dysfunction, and gastrointestinal conditions using proprietary topical formulations and nitric oxide, or NO, donor technologies | Health Technology |
VIVUS, Inc.
 VIVUS, Inc. Pharmaceuticals: MajorHealth Technology VIVUS, Inc. engaged in the development and commercialization of novel therapeutic products. The firm’s products were indicated for the treatment of obese and overweight patients, exocrine pancreatic insufficiency, and erectile dysfunction. Its products include PANCREAZE, Qsymia, and STENDRA/SPEDRA. The company was founded by Virgil A. Place in April 16, 1991 and it was headquartered in Campbell, CA. | Health Technology |
Connetics Corp.
Connetics Corp. BiotechnologyHealth Technology Connetics Corp. develops and commercializes dermatology products. The firm offers remedies for psoriasis in adults, eczema, seborrheic dermatitis, and acne. The company was founded in 1993 and is headquartered in Palo Alto, CA. | Health Technology |
The Leukemia & Lymphoma Society, Inc.
 The Leukemia & Lymphoma Society, Inc. Miscellaneous Commercial ServicesCommercial Services The Leukemia & Lymphoma Society, Inc. operates as the world's largest voluntary health organization dedicated to funding blood cancer research, education and patient services. The firm provides treatment for , lymphoma, Hodgkin's disease and myeloma, and improve the quality of life of patients and their families. It identifies and funds the most promising blood cancer research projects and forges partnerships with academic institutions, biotechnology and pharmaceutical companies to accelerate the development of new therapies. The company is headquartered in Rye Brook, NY. | Commercial Services |
| Zane Beadles Parade Foundation |
